department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Doxycycline Prasco · pharmadog

pharmadog
drugs
Doxycycline Prasco

drug

patient view →

doxycycline ER

Marketedupdated 2mo ago

by Prasco LLC

Approved

community read0 votes

all catalysts(39)

approval · 38

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

DOXYCYCLINE — FDA approval

phase 2 completion · 1

phase 2 completion

University of Benin Teaching Hospital — doxycycline (Phase II Trial Completion)

view all 39 catalysts →

News(0)

no news has mentioned this drug yet

brand

Doxycycline Prasco

generic

doxycycline

indication

Rosacea

phase

marketed

Patent cliff

source: FDA Orange Book

first barrier falls

Dec 19, 2027

~1.5 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (1)

Dec 19, 2027formulationUS 77495321.5y

Data sources

openFDA · ClinicalTrials.gov

last refreshed just now

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 8

tagApproval340 co-mentions · 170 sources
drugDOXYCYCLINE173 co-mentions · 173 sources
drugVibramycin173 co-mentions · 173 sources
drugDrug for Unspecified Dermatological Disorders173 co-mentions · 173 sources
tagSmall Molecule168 co-mentions · 168 sources
drugdoxycycline hyclate CR109 co-mentions · 109 sources
drugDoryx109 co-mentions · 109 sources
drugdoxycycline hyclate DR109 co-mentions · 109 sources

Trials studying doxycycline ER

phase2Isotretinoin vs. Doxycycline for Acneiform Rash in Patients Receiving Drugs That Target the MAPK Pathwaynot yet recruitingn=50
phase2Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinibactive not recruitingn=305
—Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infantsrecruitingn=1,600
phase4Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.recruitingn=30
phase1Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NTactive not recruitingn=18
phase2Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trialnot yet recruitingn=300
phase2Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Studycompletedn=210
phase3A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea.completedn=323

more trials →